These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 14748409)

  • 1. In vitro reactivation of acetylcholinesterase using the oxime K027.
    Kuca K; Kassa J
    Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
    Kuca K; Cabal J; Jun D; Musilek K
    Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
    Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
    Kuca K; Jun D; Bajgar J
    Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
    Kuca K; Jun D
    J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
    Worek F; Aurbek N; Thiermann H
    J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
    Jun D; Kuca K; Picha J; Koleckar V; Marek J
    Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Kassa J
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
    Antonijevic B; Stojiljkovic MP
    Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048.
    Kuca K; Sevelová-Bartosová L; Krejcová-Kunesová G
    Acta Medica (Hradec Kralove); 2004; 47(2):107-9. PubMed ID: 15446359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.